Justin B. Klee

AMLX

Justin B. Klee serves as director, officer: Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

17 trades

$9.46M

Net Position

Net Seller

$9.46M

Companies Traded

AMLX

Active Period

Jan 2023 – Mar 2026

17 total trades

Most Recent

Sell AMLX

Mar 4, 2026 · $847.5K

Justin B. Klee's Insider Trading at Amylyx Pharmaceuticals, Inc. (AMLX)

Buys

0 · $0.00

Sells

17 · $9.46M

Total Shares Bought

Total Shares Sold

591,289

AMLX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 4, 2026↗	Sell	58,564	$14.47	$847.5K	3,334,620
Feb 4, 2026↗	Sell	15,500	$14.69	$227.6K	3,363,900
Feb 2, 2026↗	Sell	15,500	$14.69	$227.6K	0
Jan 20, 2026↗	Sell	138,188	$13.59	$1.88M	3,379,400
Jan 15, 2026↗	Sell	138,188	$13.59	$1.88M	0
Jan 8, 2026↗	Sell	7,715	$11.09	$85.6K	3,317,590
Jan 6, 2026↗	Sell	7,715	$11.09	$85.6K	0
Sep 30, 2025↗	Sell	29,975	$14.38	$431.0K	0
Mar 31, 2025↗	Sell	21,490	$3.46	$74.5K	0
Mar 3, 2025↗	Sell	4,595	$3.15	$14.5K	0
Feb 3, 2025↗	Sell	11,855	$3.47	$41.1K	0
Jan 6, 2025↗	Sell	7,471	$4.04	$30.2K	0
Sep 30, 2024↗	Sell	18,589	$3.20	$59.4K	0
Mar 5, 2024↗	Sell	4,135	$18.73	$77.4K	0
Jan 9, 2024↗	Sell	5,841	$16.33	$95.4K	0
Mar 16, 2023↗	Sell	100,000	$31.86	$3.19M	0
Jan 6, 2023↗	Sell	5,968	$36.30	$216.6K	0